]>
IRCT20141108019855N7 IRCT 2019-01-28 Iran University of Medical Sciences The effect of emotional Schemas Therapy augmented exposure and response prevention on obsessive - compulsive disorder Comparison of emotional schemas therapy augmented exposure and response prevention, drug therapy and exposure and response prevention treatment on obsessive-compulsive, anxiety and depression symptoms, obsessional beliefs and quality of life in people with obsessive - compulsive disorder 2018-06-22 anticipated 45 Complete https://irct.ir/trial/35883 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients enter the treatment groups based on the lottery, Blinding description: In addition to the original researcher, the evaluator is also blind. 1-2 Obsessive-compulsive disorder. Intervention 1: Intervention group: Emotional Schemas Therapy augmented exposure and response prevention: In the initial stage (sessions 1-3), establishing a therapeutic relationship, measuring and evaluating emotional schemas, formulating the case, providing treatment logic and therapeutic goals, teaching on obsessive-compulsive disorder, and presenting a model of anthropology and explaining the treatment of emotional schema Preliminary explanation and presentation of the logic of confrontation and prevention of a brief response, attention to the patient's adaptive and non-adaptive emotions, and the presentation of the task of emotional functioning are emphasized.In the changing phase (sessions 4-10), addressing the patient's painful excitement and patient emotional schemas, and designing behavioral experiments to challenge them, presenting the task, describing emotions and challenges with troublesome emotional schemas (accepting emotions, validating emotions ) Is considered. Also, confrontational meetings begin by identifying anxiety and hierarchy.In the final phase (sessions 10-14), focusing on transferring new skills and achievements to the living environment and preventing recurrence is carried out, and the final summing up of the lessons is assessed and reassessed. Intervention 2: Intervention group 2: exposure and response prevention; The focus of these meetings is on: Reviewing the patient's reactions to the previous treatment session, Assessing the task of the previous session, logic of treatment and self-review forms, Collecting detailed information from obsessive-compulsive symptoms, Providing a hierarchy of all anxious situations, Performing confrontation with initial cases in a hierarchy (starting to confront situations with moderate anxiety), Providing treatment plan, Providing final summaries and feedback. Intervention 3: Control group: drug therapy: the patients in the control group received SSRIs. No - There is not a plan to make this available Justification or reason for not sharing IPD is No more information
public Samira Masumian
Mansouri Alley, Nayesh Street, Sattarkhan Street
Tehran Iran (Islamic Republic of) ۱۴۴۵۶۱۳۱۱۱ +98 21 6655 1616 samira.masumian@yahoo.com Iran University of Medical Sciences scientific Samira Masumian
Mansouri Alley, Nayesh Street, Sattarkhan Street
Tehran Iran (Islamic Republic of) ۱۴۴۵۶۱۳۱۱۱ +98 21 6655 1616 samira.masumian@yahoo.com Iran University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Having Diagnostic Criteria for Obsessive-Compulsive Disorder Having at least a cycle education level Having a minimum age of 18 and a maximum of 50 years 18 years 50 years Both Suicidal thoughts Psychotic disorder based on SCID-5-CV Substance use and abuse and dependence on any substance severe personality disorders F42 Obsessive-compulsive disorder Treatment - Other Treatment - Other Treatment - Drugs Intervention group: Emotional Schemas Therapy augmented exposure and response prevention: In the initial stage (sessions 1-3), establishing a therapeutic relationship, measuring and evaluating emotional schemas, formulating the case, providing treatment logic and therapeutic goals, teaching on obsessive-compulsive disorder, and presenting a model of anthropology and explaining the treatment of emotional schema Preliminary explanation and presentation of the logic of confrontation and prevention of a brief response, attention to the patient's adaptive and non-adaptive emotions, and the presentation of the task of emotional functioning are emphasized.In the changing phase (sessions 4-10), addressing the patient's painful excitement and patient emotional schemas, and designing behavioral experiments to challenge them, presenting the task, describing emotions and challenges with troublesome emotional schemas (accepting emotions, validating emotions ) Is considered. Also, confrontational meetings begin by identifying anxiety and hierarchy.In the final phase (sessions 10-14), focusing on transferring new skills and achievements to the living environment and preventing recurrence is carried out, and the final summing up of the lessons is assessed and reassessed. Intervention group 2: exposure and response prevention; The focus of these meetings is on: Reviewing the patient's reactions to the previous treatment session, Assessing the task of the previous session, logic of treatment and self-review forms, Collecting detailed information from obsessive-compulsive symptoms, Providing a hierarchy of all anxious situations, Performing confrontation with initial cases in a hierarchy (starting to confront situations with moderate anxiety), Providing treatment plan, Providing final summaries and feedback. Control group: drug therapy: the patients in the control group received SSRIs. Obsessive symptoms. Timepoint: Before, immediately after and two months after treatment. Method of measurement: Yale-Brown Obsessive-Compulsive Scale-Second Edition. Anxiety. Timepoint: Before, after and two months after treatment. Method of measurement: Four Systems Anxiety Questionnaire (FSAQ):. Obsessive beliefs. Timepoint: Before, after and two months after treatment. Method of measurement: Obsessive-Verbal Questionnaire. Quality of Life. Timepoint: Before, after and two months after treatment. Method of measurement: Quality of Life Questionnaire. Iran University of Medical Sciences Approved 2018-10-23 Ethics Committee of Iran University of Medical Sciences Next to Milad Tower, Hemat Highway Tehran Tehran Iran (Islamic Republic of)